Amphastar Pharma (AMPH) Tops Q3 EPS by 45c

Amphastar Pharma (NASDAQ: AMPH) reported Q3 EPS of $1.15, $0.45 better than the analyst estimate of $0.70. Revenue for the quarter came in at $180.6 million versus the consensus estimate of $174.63 million.

For earnings history and earnings-related data on Amphastar Pharma (AMPH) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Danone SA (BN:FP) (DANOY) PT Raised to EUR63 at Deutsche Bank
• Isabella Bank added to Russell 2000 index after Nasdaq listing